Cargando…

Novel natural killer cell-mediated cancer immunotherapeutic activity of anisomycin against hepatocellular carcinoma cells

Despite advances in the clinical management of hepatocellular carcinoma (HCC), this form of cancer remains the second leading cause of cancer-related death worldwide. Currently, there are few treatment options for advanced HCC. Therefore, novel treatment strategies for HCC are required. Here, we des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Miok, Lee, Seon-Jin, Shin, Sangsu, Park, Kang-Seo, Park, Sang Yoon, Lee, Chang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045618/ https://www.ncbi.nlm.nih.gov/pubmed/30006566 http://dx.doi.org/10.1038/s41598-018-29048-8

Ejemplares similares

Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
por: Mantovani, Stefania, et al.
Publicado: (2020)

Anisomycin protects against sepsis by attenuating IκB kinase-dependent NF-κB activation and inflammatory gene expression
por: Park, Gyoung Lim, et al.
Publicado: (2021)

Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents
por: Carreño, Leandro J, et al.
Publicado: (2016)

Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
por: Kalathil, Suresh Gopi, et al.
Publicado: (2021)

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
por: Chouaib, Salem, et al.
Publicado: (2014)

Cytotoxicity of Human Hepatic Intrasinusoidal CD56(bright) Natural Killer Cells against Hepatocellular Carcinoma Cells
por: Hwang, Shin, et al.
Publicado: (2019)

Antiviral activity of anisomycin against spring viraemia of carp virus in epithelioma papulosum cyprini cells and zebrafish
por: Shen, Yu-Feng, et al.
Publicado: (2019)

Anti-cancer activity of Angelica gigas by increasing immune response and stimulating natural killer and natural killer T cells
por: Kim, Seo Hyun, et al.
Publicado: (2018)

Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure
por: Schober, Rafaëla, et al.
Publicado: (2023)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
por: Daly, John, et al.
Publicado: (2019)

Treatment outcome of nasal natural killer/T-cell lymphoma
por: Lee, Hyun Jin, et al.
Publicado: (2011)

Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma
por: Lee, Han Ah, et al.
Publicado: (2021)

Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma
por: Zhang, Kai, et al.
Publicado: (2023)

Analysis of differentially expressed genes responsible for the suppressive effect of anisomycin on cell proliferation of DLD-1 cells
por: Ushijima, Hironori, et al.
Publicado: (2021)

Anisomycin activates JNK and sensitises DU 145 prostate carcinoma cells to Fas mediated apoptosis
por: Curtin, J F, et al.
Publicado: (2002)

Systematic Exploration of Functional Group Relevance for Anti-Leishmanial Activity of Anisomycin
por: Nguyen, Anh Minh Thao, et al.
Publicado: (2023)

Natural Killer Dendritic Cells Enhance Immune Responses Elicited by α-Galactosylceramide-Stimulated Natural Killer T Cells
por: Lee, Sung Won, et al.
Publicado: (2013)

Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge
por: You, Eunkyoung, et al.
Publicado: (2023)

Natural Killer Cell-Derived Extracellular Vesicles as a Promising Immunotherapeutic Strategy for Cancer: A Systematic Review
por: Chan, Alvin Man Lung, et al.
Publicado: (2023)

Modulation of the p38 MAPK Pathway by Anisomycin Promotes Ferroptosis of Hepatocellular Carcinoma through Phosphorylation of H3S10
por: Chen, Wei, et al.
Publicado: (2022)

A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma: Incorporation of Serum β-2 Microglobulin to PINK
por: Kang, Sora, et al.
Publicado: (2023)

An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells
por: Lee, Young Shin, et al.
Publicado: (2021)

Anisomycin prevents OGD-induced necroptosis by regulating the E3 ligase CHIP
por: Tang, Mi-bo, et al.
Publicado: (2018)

Anisomycin Activates Utrophin Upregulation Through a p38 Signaling Pathway
por: Hadwen, Jeremiah, et al.
Publicado: (2018)

Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity
por: Ehrenkaufer, Gretchen, et al.
Publicado: (2020)

Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody
por: Patel, Nishant P., et al.
Publicado: (2020)

SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential
por: Xiong, Jie, et al.
Publicado: (2021)

Natural killer (NK) cells inhibit systemic metastasis of glioblastoma cells and have therapeutic effects against glioblastomas in the brain
por: Lee, Se Jeong, et al.
Publicado: (2015)

Natural Killer Cells and Immunotherapy
por: Noh, Ji-Yoon, et al.
Publicado: (2023)

Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies
por: Lopez, Diana C., et al.
Publicado: (2022)

Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma
por: Zhuang, Lihui, et al.
Publicado: (2018)

Assessment of cellular and molecular changes in the rat brain after gamma radiation and radioprotection by anisomycin
por: Kočović, Dušica M, et al.
Publicado: (2021)

Prognostic significance of natural killer cell-associated markers in gastric cancer: quantitative analysis using multiplex immunohistochemistry
por: Na, Hee Young, et al.
Publicado: (2021)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes
por: Kim, Jung Hye, et al.
Publicado: (2019)

Natural Killer T and Natural Killer Cell-Based Immunotherapy Strategies Targeting Cancer
por: Iyoda, Tomonori, et al.
Publicado: (2023)

ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics
por: Park, Joo Dong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u4t5jk0os2dk4d2ku10itppa5o